Which ASMI member companies do pharmacists rate highest? Results revealed on awards night
The Australian Self Medication Industry (ASMI) announced the winners of its prestigious Diamond Awards for excellence in sales and marketing at the recent World Self Medication Industry (WSMI) General Assembly in Sydney last week.
The Sales Awards recognised excellence among both ASMI’s larger and smaller member with separate prize categories based on pharmacy sales more than and less than $100 million. The iLearning Group database provided the means to survey 350 pharmacists and 500 pharmacy assistants as part of the judging process.
The respondents were asked to rate ASMI member companies on six key attributes, including “quality use of medicine”. GSK won the category for pharmacy sales over $100 million, followed by Bayer and Johnson & Johnson Pacific.
In the category for sales less than $100 million, Ego came out on top, followed by Apotex and Aspen.
This year, the Marketing Awards featured a new category for Health Literacy, won by GSK for their Panadol + Voltaren Regime campaign. The judges felt that this very patient-centric campaign was outstanding for its inclusion of health literacy elements across all ‘touchpoints’ (consumer & healthcare professional (HCP)).
Among the other marketing award winners were:
Best New Product Launch – Ego Pharmaceuticals’ launch for Sunsense ‘Sensitive Invisible’
Best Small Budget Campaign – GSK’s Panadol + Voltaren Regime
Best Large Budget Campaign – Care Pharmaceuticals for the Hydralyte multi-usage occasions campaign.
Best HCP Campaign – Ego Pharmaceuticals for its QV Skin Tears in Aged Care Facilities campaign.
According to the judges, this demonstrated both “clinical and economic benefits of using QV in aged care facilities. This campaign helped develop a completely new incremental channel for QV”.